Evidence map›Paper›PMID 37049425›Full record

Trial reportNutrients2023

Consumption of Solnul

Jason R Bush, Joshua Baisley, Scott V Harding, Michelle J Alfa

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Foods (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jason R BushMSP Starch Products Inc., Carberry, MB R0K 0H0, Canada.
Joshua BaisleyNutrasource Pharmaceutical and Nutraceutical Services, Guelph, ON N1G 0B4, Canada.
Scott V HardingDepartment of Biochemistry, Faculty of Science, Memorial University of Newfoundland, St. John's, NL A1C 5S7, Canada.ORCID 0000-0002-7728-2339
Michelle J AlfaAlfaMed Consulting, Winnipeg, MB R2M 5M3, Canada.ORCID 0000-0002-0540-7438
Memorial University of Newfoundland · CANutrasource · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effects of resistant starch at high doses have been well-characterized, but the potential prebiotic effects of resistant starch at doses comparable to oligosaccharide prebiotics have not been evaluated. A three-arm randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate the effect of 3.5 g and 7 g daily doses of Solnul

Indexed as

PrebioticsSolanum tuberosumBacteriaConstipationDiarrheaDouble-Blind MethodFecesHumansResistant StarchStarchPrebioticsResistant StarchStarchAkkermansiaBifidobacteriumconstipationdiarrheamicrobiomepotatoprebioticresistant starch

Identifiers

PMID37049425
PMCPMC10097138
OpenAlexW4360850658

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.